Inter alia, has : 1. Approved the take Over of GVS Labs of Mr. S N Kamath for a consideration of Rs 160 million. The entire consideration will be paid by way of issue of shares to Mr.Kamath at a price of Rs 60/- each (at a premium of Rs 50/- each); 2. Subject to the approval of the Stock Exchange and other statutory authorities, approved Change of Name of the company from Bliss Chemicals and Pharmaceuticals India Ltd to Bliss GVS Pharma Ltd; and 3. Constituted a committee to look into the matter of further issue of shares to Mr. S N Kamath against the takeover of GVS Lab and change of name and to supervise and implement all applicable provisions of the Listing Requirements and Companies Act, 1956 and take appropriate steps for calling for the General Meeting of the members. 4. The Board of Directors will meet on May 09, 2006 to complete all the formalities relating to the above said matters. Bliss GVS Pharma Ltd has informed BSE that the members at the Extra Ordinary General meeting (EGM) of the Company held on February 15, 2007, inter alia, have transacted the following business: 1. Approved Take Over of GVS Labs for Rs 16 Cr by issue of 2,666,667 equity shares of face value of Rs 10/- each (at a premium of Rs 50/- each) to the proprietor of GVS Labs and Present Managing Director Mr. S N Kamath. The effective date of takeover of GVS Labs is April 01, 2006. 2. Increase of Authorised Share Capital of the Company from Rs 5 Crore to Rs 10 Crore. 3. Alerted the Capital clause as mentioned in the Article of Association of the Company. (As Per BSE Announcement Website Dated on 15/02/2007)